Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer Metastatic

Explore clinical trials studying Non-small Cell Lung Cancer Metastatic. Study availability and eligibility vary by location and protocol.

44 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer Metastatic trial results

Completed

Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC

NCT01848613

Conditions
Non-small Cell Lung Cancer Metastatic
Locations
  • Irccs Irst Meldola (FC), FC, Italy
  • U.O. Oncologia Ospedale Civile degli Infermi Faenza, RA, Italy
  • U.O. Oncologia Ospedale Civile Umberto I Lugo, RA, Italy
  • UO Oncologia Medica, Ospedale S.Maria delle Croci Ravenna, RA, Italy
View Trial Details
Completed

A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

NCT01473563

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linköping, Sweden
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Greater London, United Kingdom
View Trial Details
Active, Not Recruiting

HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

NCT04619004

Conditions
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Non-small Cell Lung Cancer Metastatic
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Moores Cancer Center at the UC San Diego Health La Jolla, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
View all 123 locations
View Trial Details
Active, Not Recruiting

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

NCT05689671

Conditions
Non-small Cell Lung Cancer Metastatic
Locations
  • Klinikum St. Marien Amberg, Germany
  • Universitätsklinikum Augsburg Augsburg, Germany
  • MVZ Taunus GmbH Bad Homburg, Germany
  • Evangelische Lungenklinik Krankenhausbetriebs gGmbH Berlin, Germany
View all 36 locations
View Trial Details

Related conditions